| 51 |
21677485 | Efficacy and toxicity of S-1 plus cisplatin combination neoadjuvant chemotherapy in patients with oral cancer. | 2011 Jun |
1 |
| 52 |
21773080 | An oral fluoropyrimidine agent S-1 induced interstitial lung disease: A case report. | 2011 Jul 10 |
2 |
| 53 |
21969151 | Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study. | 2011 Nov |
2 |
| 54 |
22848308 | Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer. | 2011 Nov |
1 |
| 55 |
22866104 | A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer. | 2011 May |
1 |
| 56 |
19880858 | Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer. | 2010 Jan |
1 |
| 57 |
20058135 | UFT and S-1 for treatment of primary lung cancer. | 2010 Jan |
1 |
| 58 |
20559897 | Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer. | 2010 Jul |
1 |
| 59 |
20699624 | Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study. | 2010 |
1 |
| 60 |
20716897 | [A case of interstitial pneumonitis induced by S-1]. | 2010 Aug |
1 |
| 61 |
20946314 | Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma. | 2010 Dec |
1 |
| 62 |
21079147 | Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study. | 2010 Dec 20 |
1 |
| 63 |
22966328 | Hepatic metastasis from bile duct cancer of the ampulla is effectively controlled by multidisciplinary treatment including S-1, gemcitabine and bevacizumab: A case report. | 2010 May |
1 |
| 64 |
19060295 | S-1 and gemcitabine as an outpatient-based regimen in patients with advanced or metastatic pancreatic cancer. | 2009 Jan |
1 |
| 65 |
19152726 | Adenosquamous carcinoma of maxillary sinus: case showing complete response to S-1. | 2009 Nov |
1 |
| 66 |
19243284 | S-1: a promising new oral fluoropyrimidine derivative. | 2009 Mar |
2 |
| 67 |
19377885 | A phase II study of S-1 monotherapy as second-line treatment for advanced non-small cell lung cancer. | 2009 Nov |
1 |
| 68 |
19632949 | S-1: a new oral fluoropyrimidine in the treatment of patients with advanced non-small-cell lung cancer. | 2009 Jul |
2 |
| 69 |
19638079 | Pharmacogenetics of fluoropyrimidine and cisplatin. A future application to gastric cancer treatment. | 2009 Jun |
1 |
| 70 |
19659655 | Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine). | 2009 Jul |
2 |
| 71 |
19666905 | Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent. | 2009 Nov |
1 |
| 72 |
20009476 | [A case of cancer successfully treated by chemotherapy of S-1 as first-line chemotherapy]. | 2009 Dec |
1 |
| 73 |
17520253 | A late phase II study of S-1 for metastatic pancreatic cancer. | 2008 Apr |
1 |
| 74 |
17922276 | Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients. | 2008 Feb |
1 |
| 75 |
18043133 | Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma. | 2008 Jan |
1 |
| 76 |
18363278 | S-1 monotherapy as a neoadjuvant treatment for locally advanced gastric cancer. | 2008 Mar |
1 |
| 77 |
18439695 | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer. | 2008 Jun |
1 |
| 78 |
18463956 | Current status of chemoradiotherapy for locally advanced pancreatic cancer in Japan. | 2008 Apr |
1 |
| 79 |
18544958 | Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer. | 2008 |
1 |
| 80 |
18553227 | Chemotherapy for metastatic disease: review from JCOG trials. | 2008 Jun |
1 |
| 81 |
18628737 | Is the addition of cisplatin to S-1 better than S-1 alone for patients with advanced gastroesophageal cancer? | 2008 Sep |
1 |
| 82 |
18698044 | Phase II study of combination therapy with S-1 and irinotecan for advanced non-small cell lung cancer: west Japan thoracic oncology group 3505. | 2008 Aug 15 |
1 |
| 83 |
18719349 | Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastases. | 2008 |
2 |
| 84 |
16786333 | Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer. | 2007 Feb |
1 |
| 85 |
17189072 | Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer. | 2007 Jan 1 |
1 |
| 86 |
17437021 | Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancer. | 2007 May 7 |
2 |
| 87 |
17577624 | Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer. | 2007 |
1 |
| 88 |
17611667 | Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer. | 2007 Aug |
1 |
| 89 |
17673819 | Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug. | 2007 |
1 |
| 90 |
17687220 | [A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer]. | 2007 Aug |
1 |
| 91 |
17690883 | Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients. | 2007 Oct |
1 |
| 92 |
17940390 | [Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]. | 2007 Oct |
1 |
| 93 |
17978289 | Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. | 2007 Nov 1 |
1 |
| 94 |
18079635 | [Effect of S-1 in a patient with post-operative recurrence of carcinoma of the ampulla of Vater]. | 2007 Dec |
1 |
| 95 |
18265655 | S-1 plus cisplatin combination therapy for the patients with primary liver carcinomas. | 2007 Dec |
1 |
| 96 |
16410713 | [A case of liver metastasis successfully treated with S-1 monotherapy in the patient with recurrent breast cancer]. | 2006 Jan |
1 |
| 97 |
16755122 | S-1 (TS-1) maintained complete response for approximately 10 years in a case of metastatic breast cancer. | 2006 |
1 |
| 98 |
16767370 | Histological complete response in advanced gastric cancer after 2 weeks of S-1 administration as neoadjuvant chemotherapy. | 2006 |
1 |
| 99 |
16865244 | S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU. | 2006 Sep |
2 |
| 100 |
16897968 | [Antitumor activity and function of S-1, a new oral tegafur-based formulation]. | 2006 Jun |
1 |